Abstract
Two Cebus apella monkeys with haloperidol-induced tardive dyskinesia have been studied. Substitution of chlorpromazine, thioridazine, clozapine, melperone, or fluphenazine for the daily haloperidol administration temporarily reduced the signs of tardive dyskinesia. In a monkey with low-grade symptoms, persisting for more than 100 days after with-drawal of haloperidol, neuroleptic drugs induced a typical sequence of events: first the dyskinetic movements were abolished, but 1–3 days after administration of a single dose of a neuroleptic drug there was a rebound worsening of symptoms. It was noticed that this aggravation of symptoms corresponded in magnitude and duration to the approximate liability of each compound to induce tardive dyskinesia in man. It is therefore suggested that this animal model could be used to monitor neurological side effects in neuroleptic drugs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Axelsson, R.: Clinical pharmacokinetics of a neuroleptic drug. A study of patients treated with thioridazine and thioridazine metabolites. Psychiatric Department III, University of Göteborg, Lillhagens Hospital, Göteborg. Göteborg 1977
Crane, G. E.: Persistent dyskinesia. Br. J. Psychiatry 122, 395–405 (1973)
Fann, W. E., Stafford, L. R., Wheless, J.: Tardive dyskinesia and antipsychotics. In: Animal models in psychiatry and neurology. Hanin, I., Usdin, E., eds., pp. 457–468. Oxford, New York: Pergamon 1977
Faurbye, A.: The structural and biochemical basis of movement disorders in treatment with neuroleptic drugs and in extrapyramidal disease. Compr. Psychiatry 11, 205–225 (1970)
Friedhoff, A. J.: The psychiatric clinical syndrome and essential corresponding qualities of an animal model of receptor sensitivity modification. In: Animal models in psychiatry and neurology. Hanin, I., Usdin, E., eds., pp. 51–59. Oxford, New York: Pergamon 1977
Gardos, G. G., Cole, J. O., La Brie, R. A.: Drug variables in the etiology of tardive dyskinesia. Application of discriminant function analysis. Prog. Neuro.-Psychopharmacol. 1, 147–154 (1977)
Gerlach, J., Simmelsgaard, H.: Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine and clozapine. Psychopharmacology (in press)
Gianutsos, G., and Lal, H.: Alteration in the action of cholinergic and anticholinergic drugs after chronic haloperidol: indirect evidence for cholinergic hyposensitivity. Life Sci. 18, 515–520 (1976)
Gunne, L.-M., Bárány, S.: Haloperidol-induced tardive dyskinesia in monkeys. Psychopharmacology 50, 237–240 (1976)
Hippius, H.: On the relations between antipsychotic and extrapyramidal effects of psychoactive drugs. In: Antipsychotic drugs. Pharmacodynamics and pharmacokinetics, Sedvall, G., Uvnäs, B., Zotterman, Y., eds., pp. 437–445. Oxford, New York: Pergamon 1976
Idänpään-Heikkilä, J., Alhava, E., Olkinuora, M., Palva, I.: Clozapine and agranulocytosis. Lancet 1975 II, 611
Kirkegaard, G., Kirkegaard, A.: Nebenwirkungen von Methylperone bei Dauerbehandlung bis zu 8 Jahren. Arzneim. Forsch. 24, 1115–1117 (1974)
Klawans, H. L., Hitri, A., Nausieda, A., Weiner, W. J.: Animal models of dyskinesia. In: Animal models in psychiatry and neurology, Hanin, I., Usdin, E., eds., pp. 351–364. Oxford, New York: Pergamon 1977
Kobayashi, R. M., Fields, J. Z., Hruska, R. E., Beaumont, K., Yamamura, H. I.: Brain, neurotransmitter receptors and chronic antipsychotic drug treatment: A model for tardive dyskinesia. In: Animal models in psychiatry and neurology. Hanin, I., Usdin, E., eds., pp. 405–410. Oxford, New York: Pergamon 1977
Kornetsky, C.: Animal models: Promises and problems. In: Animal models in psychiatry and neurology. Hanin, I., Usdin, E., eds., pp. 1–8. Oxford, New York: Pergamon 1977
Martin, W. R., Jasinski, D. R.: Physiological parameters of morphine dependence in man — tolerance, early abstinence, protracted abstinence. J. Psychiatr. Res. 7, 9–17 (1969)
Tarsy, D., Baldessarini, R. J.: The pathophysiologic basis of tardive dyskinesia. Biol. Psychiatry 12, 431–450 (1977)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gunne, L.M., Bárány, S. A monitoring test for the liability of neuroleptic drugs to induce tardive dyskinesia. Psychopharmacology 63, 195–198 (1979). https://doi.org/10.1007/BF00433548
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00433548